RxDoctor Payments Data

Patricia Loftus, MD

Otolaryngology · Atlanta, GANPI 1497071336

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Intersect ENT, Inc. at 27.9% of the total. That places this record below the midpoint for otolaryngology clinicians in GA, where the typical reported total is $1,278.

$1,347in general payments, 2019–2025

Across 29 payments — averaging $46.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$376
  • Stryker$368
  • Sanofi$221
  • Medtronic$87
  • Smith+Nephew$57
  • Zimvie Inc.$49
  • plus $189 from 6 others
$19,126in research payments, 2019–2025

Across 3 payments — averaging $6375.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$19K

What the payments were for

  • Food & beverage$1,347100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,347 in reported general payments places this provider in the 50th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$59,231
Medicare patients
102
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$45,656
Azelastine Hcl34$1,580
Ipratropium Bromide34$1,429
Fluticasone Propionate47$384
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$96

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →